Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain-Reference-Cited by-同舟云学术

Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain

Published:2022-08-03 Issue:7 Volume:22 Page:1127-1136
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Ángel Calleja Miguel¹^ORCID,Navarro Andrés²,Serratosa José María³,Toledo Manuel⁴,Villanueva Vicente⁵^ORCID,Subías Labazuy Silvia⁶,Gil Alicia⁶

Affiliation:

1. Pharmacy Service, Hospital Universitario Virgen Macarena, Sevilla, Spain

2. Pharmacy Service, Hospital General Universitario de Elche, Alicante, Spain

3. Epilepsy Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

4. Epilepsy Unit, Hospital Universitario Valle de Hebrón, Barcelona, Spain

5. Epilepsy Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain

6. Omakase Consulting S.L, Barcelona, Spain

Funder

Angelini Pharma España, S.L.U

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.2107507

Reference48 articles.

1. WHO. Epilepsy. [Internet]. 2019 [cited 2022 Mar 21]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/epilepsy

2. The Epidemiology of Epilepsy

3. Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based Study

4. FEEN: Informe sociosantario FEEN sobre la epilepsia en España

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA);Epilepsy & Behavior;2023-08

2. Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature;Medicina;2023-07-28

3. Failure to use new breakthrough treatments for epilepsy;Epilepsia;2023-04-11

4. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain;Epilepsy & Behavior;2023-02